Oxaliplatin but Not Irinotecan Impairs Posthepatectomy Liver Regeneration in a Murine Model
Introduction. We examined the murine hepatectomy model of liver regeneration (LR) in the setting of neoadjuvant chemotherapy. Methods. C57BL/6 mice were randomized to receive neoadjuvant intraperitoneal (IP) injections of a control, oxaliplatin (15 mg/kg), or irinotecan (100 mg/Kg or 250 mg/Kg) solu...
Saved in:
| Main Authors: | Perry A. Soriano, Nian Liu, Erick Castillo, Brock Foster, Avo Artinyan, Joseph Kim, Wendong Huang, Lawrence D. Wagman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.4061/2011/490463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer
by: Bi-Yang Cao, et al.
Published: (2025-03-01) -
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma
by: Qiang Xu, et al.
Published: (2025-07-01) -
Prophylactic administration of lecithinized superoxide dismutase for a murine model of oxaliplatin-induced myelosuppression
by: Mikako Shimoda, et al.
Published: (2025-07-01) -
An in-depth analysis of research on posthepatectomy liver failure (2006-2024): exploring trends and future directions through a bibliometric approach
by: Yachen Wu, et al.
Published: (2025-08-01) -
Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.
by: Vanesa Stojanovska, et al.
Published: (2018-01-01)